(Q40062416)

English

Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only

scientific article published on 6 August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only (English)

1 reference

Europe PubMed Central

17 September 2017

endometrial hyperplasia

1 reference

based on heuristic

inferred from title

author name string

Anne Ørbo

1

1 reference

Europe PubMed Central

17 September 2017

Marit Arnes

2

1 reference

Europe PubMed Central

17 September 2017

Christine Hancke

3

1 reference

Europe PubMed Central

17 September 2017

Anne Beate Vereide

4

1 reference

Europe PubMed Central

17 September 2017

Inger Pettersen

5

1 reference

Europe PubMed Central

17 September 2017

Kurt Larsen

6

1 reference

Europe PubMed Central

17 September 2017

language of work or name

0 references

publication date

6 August 2008

1 reference

Europe PubMed Central

17 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

17 September 2017

111

1 reference

Europe PubMed Central

17 September 2017

1

1 reference

Europe PubMed Central

17 September 2017

68-73

1 reference

Europe PubMed Central

17 September 2017

Histopathology of endometrial hyperplasia and endometrial carcinoma: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

Intrauterine progesterone treatment of early endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

Natural history of endometrial hyperplasia. Study of 77 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

Regression of latent endometrial precancers by progestin infiltrated intrauterine device

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.014

7 January 2021

Identifiers

10.1016/J.YGYNO.2008.06.014

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40062416&oldid=1883434268"